Jacqueline Moen Kadlec, in Taylor, WI - Social Worker

Jacqueline Moen Kadlec, is a Social Worker - Clinical based in Taylor, Wisconsin. Jacqueline Moen Kadlec is licensed to practice in Wisconsin (license number 133002-121) and her current practice location is 531 Sunset Pl, Taylor, Wisconsin. She can be reached at her office (for appointments etc.) via phone at (715) 662-3014.

NPI number for Jacqueline Moen Kadlec is 1871299065 and her current mailing address is 531 Sunset Pl, Taylor, Wisconsin. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1871299065.

Contact Information

	Jacqueline Moen Kadlec,
	531 Sunset Pl, Taylor, WI 54659-9515
	(715) 662-3014
	Not Available

Healthcare Provider's Profile

Full Name	Jacqueline Moen Kadlec
Gender	Female
Speciality	Social Worker - Clinical
Location	531 Sunset Pl, Taylor, Wisconsin
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1871299065
Provider Enumeration Date: 01/31/2023
Last Update Date: 01/31/2023

Medical Identifiers

Medical identifiers for Jacqueline Moen Kadlec such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1871299065	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
1041C0700X	Social Worker - Clinical	133002-121 (Wisconsin)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Jacqueline Moen Kadlec is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Jacqueline Moen Kadlec, 531 Sunset Pl, Taylor, WI 54659-9515 Ph: () -	Jacqueline Moen Kadlec, 531 Sunset Pl, Taylor, WI 54659-9515 Ph: (715) 662-3014

News Archive

EGFR-targeted therapy improves survival rates in metastatic colorectal cancer patients

Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced that Erbitux® (cetuximab) demonstrated a significant improvement in overall survival (OS) when added to standard 1st-line chemotherapy for metastatic colorectal cancer (mCRC) patients with KRAS wild-type tumors.

Ritalin drug used to treat hyperactive children boosts the potency of Parkinson's drug levodopa

A well-known drug used to treat hyperactive children boosts the potency of another drug that reduces Parkinson's disease symptoms, an Oregon Health & Science University study has found.

Results of fiscal year 2009 announced by Biomerica

Biomerica, Inc. (OTCBB: BMRA), a global provider of advanced diagnostic products for the early detection of medical conditions, today reported net sales for the fiscal year 2009 were $4,934,771 versus net sales of $4,926,505 in fiscal 2008.

Study: Medication use is common in pregnant women with preeclampsia

Use of medications during pregnancy is more common in women with preeclampsia than in those without, according to an analysis of women who gave birth at a hospital in Finland in 2002-2016.

Dopamine agonist therapy for Parkinson's disease may lead to problem gambling

Eleven patients with Parkinson's disease (PD) developed pathological gambling behavior following dopamine agonist therapy, a drug therapy to control movement problems caused by Parkinson's disease, according to a study posted online which will appear in the September print issue of Archives of Neurology.

Jacqueline Moen Kadlec, - Clinical Social Worker in Taylor, WI